Iva Lukac
Director of AI in Drug Discovery, Apheris
Iva Lukac is listed as Director of AI in Drug Discovery, Apheris. B2DB records 2 sessions at 1 conference in 2026, most recently Drug Discovery Chemistry Europe 2026 (November 2026). Speaks mainly at Hospitals and Health Care events.
Compiled from published conference agendas; not yet confirmed by Iva. Is this you? Claim this profile.
- Sector: Hospitals and Health Care
About
Iva is a Director of AI in Drug Discovery at Apheris, with more than a decade of experience spanning computational chemistry, AI and drug discovery in academia and industry. Her work focuses on applying molecular modelling, structure-based design and machine learning to complex drug discovery challenges. Before joining Apheris, she held scientific roles at Isomorphic Labs, Charnwood Discovery and Drug Discovery Unit in Dundee.
Sessions at 1 conference
Drug Discovery Chemistry Europe 2026 11 November 2026 – 12 November 2026
- A Foundational Shift in AI-driven Drug Discovery: Improving Co-Folding Models with Federated Networks Speaker · 11 November 2026
- Panel Discussion: From Molecules to Medicines: How AI Foundation Models are Reshaping Drug Discovery Panellist · 11 November 2026
Spoke alongside
People who have shared a session with Iva at events on B2DB.
- Ashwini Ghogare GenAI Leader for Start-ups, Life Sciences and Healthcare · Amazon Web Services 1 shared session
- Steven Crossan CEO & Founder · Dayhoff Labs 1 shared session
- Fanny Jaulin CEO & Cofounder · Orakl Oncology 1 shared session
- Gustave Ronteix Co-Founder and CTO · Orakl Oncology 1 shared session
- Lindsay Edwards CTO · Relation Therapeutics Ltd. 1 shared session
- Jeremy Wohlwend CTO · Boltz 1 shared session